Related Experiment Video

Updated: Apr 16, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

12.2K

MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1

Guoqing Duan1, Chunfeng Ren, Yuanmin Zhang

  • 1Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|March 13, 2015
PubMed

Insights

MicroRNA-26b (miR-26b) is downregulated in osteosarcoma, promoting tumor metastasis by increasing connective tissue growth factor (CTGF) and Smad1 expression. Restoring miR-26b levels inhibits osteosarcoma cell migration and lung metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-26b (miR-26b) dysregulation is implicated in various cancers.
  • The role of miR-26b in osteosarcoma remains unexplored.

Purpose of the Study:

  • To investigate the role of miR-26b in osteosarcoma.
  • To identify the targets of miR-26b in osteosarcoma cells.

Main Methods:

  • Quantitative real-time PCR and Western blotting to measure miR-26b, CTGF, and Smad1 expression.
  • Luciferase reporter assays to confirm direct targeting.
  • In vitro cell migration assays and in vivo lung metastasis models.

Main Results:

  • miR-26b was significantly downregulated in osteosarcoma tissues and negatively correlated with CTGF and Smad1 expression.
  • miR-26b directly targeted CTGF and Smad1, suppressing their expression and osteosarcoma cell migration.
  • CTGF and Smad1 mediated osteosarcoma cell migration and invasion.
  • miR-26b overexpression inhibited osteosarcoma lung metastasis in vivo.

Conclusions:

  • Downregulation of miR-26b contributes to osteosarcoma progression and metastasis.
  • miR-26b acts as a tumor suppressor in osteosarcoma by targeting CTGF and Smad1.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

10.0K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K